JAK2 and essential thrombocythemia: The WHO classification system for MPNs includes seven subcategories (3), but more commonly this refers to the JAK2 mutation-enriched diseases polycythaemia vera (PV), essential thrombocythaemia (ET) and primary myelofibrosis (PMF).